Hudson Bay Capital Management
GRCL

Hudson Bay Capital Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Hudson Bay Capital Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-266,667
Closed -$2.68M – 955
2023
Q4 		$2.68M Sell
266,667
-1,733,333
-87% -$7.87M 0.02% 409
2023
Q3 		$1.13M Buy
+2,000,000
New +$7.31M 0.01% 545

Hudson Bay Capital Management's GRCL Position: Q1 2024 in Review

Hudson Bay Capital Management sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 266,667 shares — an estimated $2.68M sold.

Hudson Bay Capital Management first reported a position in GRCL in Q3 2023 and held it in 2 quarters. The position peaked at $2.68M in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

  • Hudson Bay Capital Management reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Hudson Bay Capital Management sold 266,667 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $2.68M.
  • Hudson Bay Capital Management first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q3 2023 and held it in 2 quarters.
  • Hudson Bay Capital Management's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $2.68M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Hudson Bay Capital Management's 13F filing for Q1 2024, filed 15 May 2024.